Empasug -M 500/12.5 - Empagliflozin 12.5 mg + Metformin 500 mg IR | Intralife Pharmaceuticals
DIASAGE
FeaturedTop

Empasug -M 500/12.5

MRP: 1,600

Packaging: 10X10

Pack Type: tablet

Composition:

Empagliflozin 12.5 mg + Metformin 500 mg IR

Indication:

Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and biguanide (Metformin) for dual action on glucose regulation. Not for type 1 diabetes or diabetic ketoacidosis.

Description:

Empagliflozin 12.5mg + Metformin 500mg IR (Immediate Release) is a fixed-dose combination tablet designed to manage type 2 diabetes mellitus effectively. This combination leverages two complementary mechanisms:

  • Empagliflozin (12.5mg): A Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor that helps lower blood glucose by promoting renal excretion of glucose through urine.

  • Metformin (500mg): A biguanide that decreases hepatic glucose production and improves peripheral insulin sensitivity.

The immediate-release formulation ensures rapid absorption and effective glucose lowering throughout the day. This combination is ideal for patients who need enhanced glycemic control with cardiovascular and renal protective benefits. It supports better blood sugar management while helping with weight control.

Tags:

Type 2 Diabetes Combination Therapy SGLT2 Inhibitors Biguanides Immediate Release Oral Antidiabetics Prescription Medicines
  • Effective dual action lowers blood glucose
  • Supports weight management
  • Offers cardiovascular and kidney protection
  • Improves insulin sensitivity and glucose elimination
  • Convenient combination therapy reduces pill burden

Usage Information

Dosage

Take one tablet twice daily with meals (usually breakfast and dinner). Follow healthcare provider’s dosing recommendations. Maintain hydration during therapy.

Side Effects

Common side effects: Nausea, diarrhea, abdominal discomfort Increased urination Thirst or dry mouth Genital yeast infections Mild headache Serious side effects (rare): Lactic acidosis Diabetic ketoacidosis Hypotension Acute kidney injury

Contraindications

Type 1 diabetes Diabetic ketoacidosis Severe renal impairment (eGFR < 30 mL/min/1.73m²) Liver disease or metabolic acidosis Hypersensitivity to Empagliflozin or Metformin Conditions causing dehydration or severe infections

Availability

Empagliflozin 12.5mg Metformin 500mg IR Empagliflozin Metformin combination tablets SGLT2 inhibitor with Metformin IR Type 2 diabetes oral treatment Blood sugar control medication Diabetes combination therapy Empagliflozin Metformin side effects

Empagliflozin 12.5mg + Metformin 500mg | Intralife Pharmaceuticals | Intralife